The objective of this study was to identify FLT3 alterations in patients with B-ALL and to correlate these alterations with their clinical course to clarify whether FLT3 is a molecular marker of clinical relevance in children with B-ALL. Here, FLT3 is linked to acute lymphoblastic leukemia.